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Abstract
Background: Although the transcription factor Pax6 plays an essential role in neurogenesis, layer
formation and arealization in the developing mammalian cortex, the mechanisms by which it
accomplishes these regulatory functions are largely unknown. Pax6 and the ETS family transcription
factor Er81, which is presumed to play a role in the specification of a sublineage of layer 5 projection
neurons, are expressed with a prominent rostrolateral-high to caudomedial-low gradient in cortical
progenitors. In the absence of functional Pax6, progenitors do not express Er81  and the
rostrolateral cortex lacks Er81-positive layer 5 neurons. In this study, we investigated the
transcriptional regulation of Er81 and provide evidence that Er81 is a direct target of Pax6.
Results:  We identified and analyzed the regulatory function of an evolutionarily conserved
upstream DNA sequence in the putative mouse Er81 promoter. Three potential Pax6 binding sites
were identified in this region. We found that the presence of one of these sites is necessary and
sufficient for full activation of the Er81 promoter in Pax6-transfected HeLa cells, while other still
unknown factors appear to contribute to Er81 promoter activity in cortical progenitors and
neuronal cells. The results suggest that endogenous Pax6, which is expressed at the highest level
in progenitors of the rostrolateral cortex, exerts region-specific control of Er81 activity, thus
specifying a subpopulation of layer 5 projection neurons.
Conclusion: We conclude that the genetic interplay between the transcription factors, Pax6 and
Er81, is responsible, in part, for the regional specification of a distinct sublineage of layer 5
projection neurons.
Background
In the mammalian neocortex (pallium), neurons with
striking morphological and functional diversity are organ-
ized radially in six layers, and tangentially into numerous
functional domains. Only recently have the molecular
and cellular mechanisms that guide the process of cortico-
genesis responsible for this organization begun to be
resolved [1,2]. The main source of cortical projection neu-
rons is the population of pluripotent radial glial progeni-
tors (RG), which divide asymmetrically at the apical
surface of the ventricular zone (VZ) and generate both
neuronal and glial progeny [3]. After midgestation, RG
generate neuronal progenitors, termed intermediate or
basal progenitors (BPs), that divide symmetrically at the
basal surface of the VZ and in the subventricular zone
(SVZ). Thus, while the asymmetric division of RG progen-
itors gives rise to progeny with distinct cell fates, the sym-
metric division of BPs primarily modulates the number of
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cells in previously established neuronal cell lineages [4].
The projection neurons of the lower (6 and 5) and upper
(4–2) layers are generated predominantly from early
(E12-E14) or late (E15-E18) progenitors in the two germi-
native zones, VZ and SVZ, respectively. Although gener-
ated during a specific developmental window, each
neuronal layer consists of molecularly distinct neuronal
subtypes that arise sequentially [5-7]. For instance, the
majority of layer 5 neurons that extend corticospinal pro-
jections express the transcription factor, Er81 [8], while
another set of layer 5 neurons, marked by the expression
of the homeodomain transcription factor, Otx1, make
connections with the superior colliculus and pons [5].
Thus, laminar fate is presumably determined not only by
the timing of neuronal origin during distinct develop-
mental stages, a process controlled by environmental cues
[9], but is also critically dependent on intrinsic mecha-
nisms that control the molecular phenotype of the neuro-
nal sublineages [5]. The mechanisms that control the
restricted expression of molecular determinants in distinct
classes of neurons during corticogenesis remain
unknown. Our previous results, as well as those of other
groups, have indicated that neurogenic RG progenitors are
intrinsically specified by the expression of Pax6 [10]. In
the absence of Pax6, as exemplified by Pax6/Small eye
homozygous (Sey/Sey) embryos, cortical progenitors pro-
duce less than half the normal number of neurons; con-
versely, retroviral-mediated Pax6 overexpression in
cortical progenitors in vitro results in expanded produc-
tion of neuronal progeny [11,12]. Pax6  is strongly
expressed in early progenitors and, although it directly
regulates the activity of the neuronal determination gene,
Ngn2 [13]. Ngn2- and Pax6-controlled genetic programs
appear to specifically and separately determine the neuro-
nal fate of lower and upper neurons [14]. Thus, Ngn2
knock out (KO) and Sey/Sey  embryos exhibit selective
misspecification of lower and upper cortical layer neu-
rons, respectively [14]. Intriguingly, however, in the
absence of Pax6, cortical progenitors fail to express the
layer 5-specific marker, Er81, which instead exhibits
enhanced ectopic expression in the SVZ [15]. We have
noted qualitatively similar mispatterning of Er81 expres-
sion in the rostrolateral cortex in the cortex-specific condi-
tional Pax6 KO mice at juvenile and adult stages (T.C.T.,
A.S. unpublished observations), prompting us to examine
possible genetic interactions between the two transcrip-
tion factors, Pax6 and Er81.
Here we report the identification of a 2-kb promoter
sequence of the mouse Er81 gene that drives Er81 expres-
sion in a subpopulation of cortical layer 5 neurons. We
demonstrate that Pax6 directly controls Er81 activity in
both cortical progenitors and in a subset of layer 5 projec-
tion neurons. The results further suggest that the cell fate
specification of Er81-positive layer 5 neurons in the rost-
rolateral cortex is a Pax6-dependent process.
Results
Pax6 binds to the putative Er81 promoter
DNA sequences with significant gene regulatory functions
are highly conserved during evolution. A comparison of
the Er81 locus from mouse, rat, chimpanzee and human
revealed the existence of a highly conserved sequence of
approximate 2 kb in the 5' region of the putative Er81 pro-
moter. To identify potential Pax6 consensus binding sites
[16] in this region, we utilized the sequence analysis pack-
age GCG [17]. We discovered three potential Pax6 bind-
ing sites located at positions -113 to 148, -1190 to 1225,
and -1530 to 1565 upstream of the mouse Er81 gene, each
of which contained three, four or five mis-matches relative
to the consensus Pax6 binding sequence [16]. Using an
electrophoretic mobility shift assay (EMSA) and in vitro-
translated Pax6 protein, we examined Pax6 binding to
these three potential binding sites. The results indicate
that Pax6 bound with low affinity to the Pax6 binding site
at position -1190 to -1225, but not to any of the other
putative sites (Fig. 1B, lanes 3 and 6 and data not shown).
To determine whether this low-affinity binding was spe-
cific, we pre-incubated binding mixtures with an anti-
Pax6 antibody and found that protein-bound, radiola-
beled probes were supershifted, confirming the presence
of a DNA-Pax6 protein-Pax6 antibody complex (Fig. 1B
lane 7). Pax6 binding was also completely abolished after
mutating the binding site sequence in the Er81 promoter
(Fig. 1A,B lanes 9, 10). Together, these findings indicate
that Pax6 interacts specifically with the -1190-1225 regu-
latory sequence of the Er81 promoter.
To determine whether this binding site is occupied by
Pax6 protein in vivo, we performed chromatin immuno-
precipitation (ChIP) assays using mouse E15.5 cortical
extracts. A 282-bp fragment located at -1322 to -1040 of
the Er81 promoter encompassing the Pax6 binding site
was precipitated from chromatin by the Pax6 antibody
(Fig. 1C, lane 2), but not by pre-immune serum (Pre) or
GFP antibody (Fig. 1C, lane 1 and 3). Furthermore, the
Pax6 antibody was not able to precipitate a control chro-
matin fragment isolated from a region outside of the puta-
tive Er81 promoter (Fig. 1C, lane 5). These data indicate
that Pax6 protein binds specifically to the putative Er81
promoter both in vitro and in vivo.
Significantly, the identified Pax6 binding site is also
present in the 2-kb upstream-region of the Er81 gene of
mouse, rat, chimpanzee and human (data not shown)
and in zebrafish [18], suggesting that this binding site is
evolutionally conserved.BMC Developmental Biology 2008, 8:23 http://www.biomedcentral.com/1471-213X/8/23
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Pax6 bind specifically to a putative Er81 promoter Figure 1
Pax6 bind specifically to a putative Er81 promoter. (A) The schematic depicts the putative Er81 promoter, showing the 
relative positions of a potential Pax6-binding site (BS) and an external control sequence used for ChIP assays (see below). A 
comparison of the DNA sequences for the potential Pax6-binding site identified in the putative Er81 promoter (at position -
1190-1225), the perfect Pax6-binding site (Cons), and the mutated site (Mut) is also indicated. (B) EMSA analysis of Pax6 bind-
ing to 32P-labeled probes corresponding to the potential Pax6 binding site, a perfect Pax6-binding site, and a mutated site. The 
arrows, open arrowhead and closed arrowhead indicate free probes, probe-protein complexes, and probe-protein-antibody 
complexes, respectively. Binding of Pax6 to its perfect Pax6-binding site (lane 3) and potential binding site in the putative Er81 
promoter (lane 6) is clearly detectable. Probe binding is not observed using the TNT rat reticulocyte lysate (RRL) as a protein 
control (lanes 2, 5). Binding specificity was confirmed by pre-incubating with an anti-Pax6 antibody, which resulted in a super-
shifted DNA-Pax6 protein-Pax6 antibody complex (lanes 4, 7). Binding of Pax6 was completely abolished by mutation of the 
Pax6 binding-site sequence in the Er81 promoter (lanes 9, 10). (C) ChIP assay. Pax6 antibodies precipitated chromatin contain-
ing the Pax6 binding site in the region -1322 to -1040 of the Er81 promoter (lane 2), but were unable to precipitate chromatin 
isolated from a region outside of the Pax6 binding site (lane 4). Preimmune serum (lane1, Pre) or GFP (lane3) antibodies failed 
to precipitate chromatin.BMC Developmental Biology 2008, 8:23 http://www.biomedcentral.com/1471-213X/8/23
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Cell type-dependent regulation of Er81 promoter activity
We next used deletion analysis to determine the minimal
sequence requirements for Er81 promoter activity. A 3.5-
kb fragment from the 5' region of the mouse Er81 gene
and a series of deletion fragments were subcloned into
luciferase reporter plasmids and transfected into mouse
primary embryonic (E12.5) cortical cell cultures, as
described below (Fig. 2A). The Er81(wt)-Luc  construct
(p131), containing a 2-kb region of genomic DNA
upstream of the Er81  translation initiation codon, was
most active in subsequent luciferase assays.
To assess the ability of Pax6 to activate the Er81 promoter,
we transfected HeLa cells, which lack endogenous Pax6
[19], with Er81(wt)-Luc alone (control) or together with
the Pax6-expression plasmid, CMV-Pax6  (Fig. 3A). The
control cells exhibited very low basal levels of luciferase
activity, whereas co-transfection of Er81(wt)-Luc  with
increasing amounts of CMV-Pax6 led to robust, concen-
tration-dependent increases in luciferase activity (Fig. 3A).
To determine whether Pax6 is also able to activate the
Er81 promoter in vivo, we performed in ovo co-electropo-
ration experiments. Er81(wt)-Luc  and  CMV-Pax6  con-
structs (or a CMV-Gfp  empty vector control), were
electroporated into the hindbrain of Hamburger and
Hamilton (HH) stage 11–12 chick embryos. After 2 days,
embryos were examined immunohistochemically for
expression of Pax6, GFP and luciferase reporter. After the
forced expression of Pax6 in VZ progenitors of the hind-
brain, a marked expression of the Er81-luciferase reporter
was detected as compared to the controls (Fig. 3E/I). In
developing neural tube Er81 is expressed endogenously
only in differentiated motor and proprioceptive sensory
neurons, including a subpopulation of neurons of the
inferior olive in the hindbrain [20,21]. Upon electropora-
tion, the injection in the forth ventricle, DNA (through
the CMV-Pax6 construct) is incorporated in VZ progeni-
tors and their descendents, seen as strongly luciferase-pos-
itive cells leaving the neural tube (Fig. 3H). Consistent
results were also obtained when the forced expression of
Pax6 was tagged predominantly into the isthmic region,
normally being negative for endogenous Pax6 expression
(Fig. 3L/M). Together, these results indicate that forced
expression of Pax6 can trans-activate the Er81 promoter in
both, a cell culture system and a live embryo.
To further examine the functional significance of the sin-
gle Pax6 binding site identified in the Er81 promoter, we
mutated the site in the Er81(wt)-Luc plasmid from the
original 5' CCCGCT 3' sequence to 5' CTCGAG 3', which
does not bind Pax6, generating the Er81(mut)-Luc plas-
mid (Fig. 1A,B). We then used a reporter assay to assess
the Pax6-dependent transactivation of both wild type and
mutated constructs. Accordingly, HeLa cells were trans-
fected with Er81(wt)-Luc or Er81(mut)-Luc with or with-
out cotransfection of the Pax6 expression construct, CMV-
Pax6. As expected, the activity of the wild-type promoter
construct was enhanced by Pax6 overexpression, which
increased luciferase activity almost 20-fold compared to
the reporter activity in control cells. Mutation of the Pax6-
binding site in the putative Er81  promoter completely
abolished Pax6-dependent activity in the reporter assay
(Fig. 3B). These data suggest that, in Pax6-transfected
HeLa cells, a single biologically active Pax6-binding site in
the Er81 promoter is sufficient to support full promoter
activity.
To study how the occupation of the binding site by Pax6
in the Er81  promoter is influenced by the presence of
endogenous proteins intrinsic to progenitor cells, we eval-
uated  Er81  promoter activity in primary embryonic
(E12.5) cortical cultures. More that 90% of the RC2+ RG
progenitors express Pax6 at this stage [10,22]. The cells
were electroporated with either Er81(wt)-Luc, Er81(mut)-
Luc or empty pGL3 plasmid (control) and cultured for 3
days  in vitro (3DIV) in a chemically defined culture
medium (see Materials and Methods; [23]). Under these
conditions, progenitor proliferation and neuronal differ-
entiation  in vitro mimic  in vivo neurogenesis [10,24].
Notably, in contrast to Pax6-transfected HeLa cells, where
transfection of the Er81(mut)-Luc  construct completely
abolished Er81 promoter activity, approximately 42% of
the residual luciferase activity remained in primary corti-
cal cultures transfected with this mutant promoter con-
struct (Fig. 3C). These findings indicate that the Pax6-
binding site in the Er81 promoter is an important, but
possibly not the sole, cis-acting element responsible for
regulating the activity of the Er81 promoter in cortical pri-
mary cultures.
Pax6 is expressed in RG progenitors, but is also present in
some differentiated neurons in the adult brain, including
some amygdalar nuclei [25]. Upon differentiation, pri-
mary cortical cultures contain a mixture of progenitors
and different cell types, including neurons and glial cells.
To examine the function of the Pax6 binding site identi-
fied in the Er81 promoter in a homogeneous neuronal cell
population, we performed Er81 reporter assays using the
neuronal cell line, Neuro-2A, which expresses little or no
Pax6 [26]. Neuro-2A cells were transfected with either
Er81(wt)-Luc, Er81(mut)-Luc or pGL3 constructs and cul-
tured for 2 days. In agreement with the results obtained in
primary cortical cells, transfection of Neuro-2A cells with
the  Er81(wt)-Luc  construct caused almost a four-fold
increase in luciferase reporter activity compared to that in
pGL3-transfected control cultures (Fig. 3D). Remarkably,
and in contrast to the experiments with Pax6-transfected
HeLa cells and mixed primary cortical cultures, transfec-
tion of Neuro-2A cells with Er81(mut)-Luc construct hadBMC Developmental Biology 2008, 8:23 http://www.biomedcentral.com/1471-213X/8/23
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Characterization of the Er81 promoter Figure 2
Characterization of the Er81 promoter. (A) Diagram to the left indicates the relative size of deletion constructs used in 
the reporter assay. The horizontal lines represent deleted fragments of the putative Er81 promoter. Diagram to the right 
shows the corresponding reporter activities of the indicated deletion constructs in primary cortical cell cultures, expressed as 
mean ± standard deviation (error bars) in each assay. The asterisk masks the construct, p131 with the highest luciferase activity 
among other deletion constructs. (B) Multiple sequence alignment of the mouse, rat, chimpanzee, and human Er81 genes was 
performed using the ClustalW algorithm implemented in the eShadow web application [55]. The x- and y-axes indicate the dis-
tance (in base pairs) to the starting codon (0) and percentage variation, respectively. The resulting alignment indicates a highly 
conserved sequence of approximate 2 kb upstream of the Er81 gene for all species examined. Schematic representation of the 
vector used to generate a Cre-transgenic mouse line in which the expression of Er81 is driven by the identified 2-kb Er81 pro-
moter sequence. The Er81 promoter was subcloned upstream of the β-globin minimal promoter (minPr) in a plasmid contain-
ing a DNA fragment encoding Cre [53]. This construct allows the Er81 promoter to simultaneously drive expression of Cre via 
the β-globin minimal promoter, and a GFP reporter sequence via an IRES sequence. (C) After crossing with Gtrosa26tm1Sho 
reporter mice [27], LacZ staining of E16.5 forebrains isolated from double-transgenic Er81Cre Gtrosa26 mice showed recom-
bination in the L5, and the VZ of cortex, striatum, piriform cortex, and olfactory bulb (C, cross section; D, sagittal section). CP, 
Cortical plate; Hi, Hippocampus; L5, Layer 5; OB, Olfactory bulb; Pir, Piriform cortex; Str, Striatum; VZ, Ventricular zone.BMC Developmental Biology 2008, 8:23 http://www.biomedcentral.com/1471-213X/8/23
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The Pax6 binding site is required for full activity of the putative Er81 promoter Figure 3
The Pax6 binding site is required for full activity of the putative Er81 promoter. (A) Exogenously expressed Pax6 
activated a co-transfected Er81 promoter-reporter construct in HeLa cells in a dosage-dependent manner. (B) Mutation of the 
Pax6 binding site completely abolished Pax6-dependent luciferase reporter activity of the putative Er81 promoter in HeLa cells. 
The plasmid combinations used for transfections are indicated. (C) Mutation of the Pax6-binding site led to a significant 
decrease in Er81 promoter activity in mouse embryonic (E12.5) primary cortical cultures. (D) The putative Er81 promoter 
exhibited high activity in Neuro-2A cells (compare Er81(wt)-luc construct and control pGL3). Deletion of the Pax6 binding site 
did not affect activation of the putative Er81 promoter in Neuro-2A cells (compare Er81(wt)-luc and Er81(mut)-luc constructs). 
(E-K) Pax6 activated an Er81 promoter-reporter construct in ovo. (E) GFP immunoreactivity demonstrates the high efficiency of 
the electroporation method. (E/F) After co-electroporation of Er81(wt)-Luc and CMV-eGFP, no luciferase-positive cells were 
detected. (G-I) Co-electroporation of Er81(wt)-Luc and CMV-Pax6 promoted expression from the Er81 promoter-luciferase 
reporter construct in hindbrain of chick embryos. (K) The table shows the number of embryos used for immunohistochemical 
analyses and the results obtained with the indicated antibodies. The strength of the immunohistochemical signal is designated as 
no, weak or strong staining. Note that the images shown in (E-H) represent strong staining for GFP, Luciferase and Pax6 anti-
bodies. (L/N) Consistently, co-electroporation of Er81(wt)-Luc and CMV-Pax6 in isthmic region, where Pax6 does not express, 
led to up-regulation of the Er81 promoter-controlled luciferase reporter. Arrows in images for the whole embryo indicated a 
region where plasmids were injected. Luciferase activity is expressed as mean ± standard deviation (error bars) in each assay. 
Er81(wt)-Luc, wild-type putative Er81 promoter-reporter construct; Er81(mut)-Luc, mutated putative Er81 promoter-reporter 
construct.BMC Developmental Biology 2008, 8:23 http://www.biomedcentral.com/1471-213X/8/23
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no effect on Er81 promoter activity (Fig. 3D). As noted
above, Pax6 binds with low affinity to the Er81 promoter,
suggesting that high levels of Pax6  expression may be
required to exert transcriptional control on Er81. Under
the culture conditions used, Pax6 expression in mixed pri-
mary cortical cultures is restricted to the RG progenitors
cells. Collectively, these findings strongly suggest that the
Pax6 binding site identified in the Er81 promoter is essen-
tial for activation of Er81 in cortical progenitors, while
regulation of Er81  expression in neuronal cells may
depend on other factors.
The 2-kb Er81 promoter sequence drives appropriate 
expression of Er81 in the cortex of Er81Cre transgenic 
mice
To obtain definitive evidence that the promoter sequences
identified in the Er81 gene is capable of correctly driving
the endogenous expression of Er81  in the developing
brain, we developed an Er81Cre transgenic mouse. This
line expresses a DNA construct containing a 2.0-kb frag-
ment of the Er81  promoter placed downstream of a
human β-globin minimal promoter, followed by a Cre
recombinase DNA sequence, and IRES and GFP reporter
sequences (Fig. 2B). Er81Cre transgenic mice were crossed
with mice from a reporter line, Gtrosa26tm1Sho [27], which
contain a loxP-flanked DNA sequence of "stopper" frag-
ment positioned upstream of the β-galactosidase-neomy-
cin phosphotransferase fusion gene (β-geo).  β-geo is
expressed only after Cre-mediated excision of loxP-
flanked DNA sequences, and thus double-reporter trans-
genic Gtrosa26tm1Sho/Cre lines provide a region-specific
report of the occurrence of Cre excision by the specific Cre
line used [27]. The analysis of LacZ activity at E16.5 in dif-
ferent Er81Cre;Gtrosa26tm1Sho double-transgenic founders
revealed expression of the reporter in the VZ and layer 5 of
the cortex, striatum, piriform cortex and olfactory bulb, a
result that is in agreement with the known pattern of Er81
expression in the mouse telencephalon (Fig. 2C,D;
[18,28]). We therefore conclude that the 2-kb Er81 pro-
moter region is necessary and sufficient for Er81 expres-
sion in the mouse telencephalon.
Discussion
Accumulating evidence suggests that the process of corti-
cal layering, during which progenitor cells in the VZ and
SVZ generate neurons destined to specific cortical layers,
depends on both the temporal sequence of progenitor cell
origination during a specific developmental stage and the
expression of layer-determinant genes. In addition, neu-
rons of a specific layer exhibit diversity in number, mor-
phology and axonal connectivity across different
functional domains of the cortex. Thus, the two funda-
mental processes of corticogenesis, layering and arealiza-
tion, seem to be closely related. According to the current
view, the functional regionalization of the cortex involves
intrinsic mechanisms, controlled by the combinatorial
expression of transcription factor gradients in the progen-
itors, and extrinsic cues provided by the ingrowing tha-
lamocortical axons at late developmental stages and after
birth [2,29].
In the developing cortex, Pax6 is expressed in RG progen-
itors in a rostrolateral-high to caudomedial-low gradient
[30,31] and plays essential roles in cortical neurogenesis,
and arealization and layer formation [10,12,14,25,30,32-
37]. Accordingly, abolishing Pax6 function leads to
defects in cortical molecular regionalization as observed
in the Pax6/Small eye brain, where the rostral cortical area
shrinks and caudal areas expand [38,39]. Furthermore,
there is a decrease in the number of neurons in the Pax6-
defficient cortex, in which the neuronal subsets of the
upper cortical layers appear to be specifically missing
[14,34]. In the current study, we provide the first evidence
that Pax6 may determine the neuronal identity of subsets
of layer 5 projection neurons by controlling the expres-
sion of Er81 in pallial progenitors.
Er81 is a member of the Pea3 subfamily of the ETS tran-
scription factor family [40] that is expressed in cortical
progenitors at the mid- to late stages of neocortical devel-
opment in mouse [28], rat and monkey [41]. In the
mouse cortex, Er81 transcripts are first detected at E13 in
the VZ of the rostrolateral pallium; expression is main-
tained in a subset of the pyramidal cells in the lower part
of layer 5 in later embryonic stages and in the mature
brain. [41]. ETS proteins have been shown to contribute
to the specification of various cell types in vertebrates and
invertebrates [42]. The documented role of Er81 in the
specification of dendritic arborization of proprioceptive
sensory neurons in the spinal cord [43] suggests the pos-
sibility that Er81 might be involved in the neuronal sub-
type specification of projection neurons in the cortex
[18,28]. Similar to Pax6, Er81 is also expressed in a prom-
inent, graded manner in pallial progenitors, reaching its
highest levels in the rostrolateral cortex [28,44,45]. In the
absence of Pax6, Er81 expression in the VZ of the rostrola-
teral cortex (where endogenous Pax6 expression is high-
est) is essentially undetectable, both in Sey/Sey mutant
[15] and in the juvenile cortex of the conditional cortex-
specific  Pax6KO  mutant, (T.C.T and AS, unpublished
data). We show here that Pax6 binds with low affinity to
a single binding site in the Er81 promoter, and further
show that Pax6 protein produces dose-dependent
increases in the activity of this promoter. Collectively,
these findings suggest that Pax6 controls the generation of
Er81+ layer 5 neurons in a dose- and region-specific man-
ner, predominantly in the motor and frontoparietal cor-
tex. Remarkably, similar region- and dose-dependent
regulation of Er81 expression by the neurogenic factor,
Ngn2, was demonstrated in Ngn2-KO mice, in which Er81BMC Developmental Biology 2008, 8:23 http://www.biomedcentral.com/1471-213X/8/23
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expression is specifically affected only in the rostral cortex
[14]. Ngn2 is a direct Pax6 downstream target gene whose
expression is regulated by high levels of Pax6 expression
only in progenitors of the rostral pallium [13,35]. Addi-
tional experiments will be required to determine whether
Er81  expression in the rostrolateral cortex is regulated
coordinately by Pax6 and Ngn2 or, alternatively, whether
Er81  acts as a downstream regulator in the Pax6-Ngn2
pathway.
We found that the Pax6-binding site identified in the 2-kb
promoter fragment of Er81 was necessary for full activa-
tion of the Er81 promoter by Pax6 in Pax6-transfected-
HeLa cells. However, mutation of the Pax6-binding site
only partially reduced Er81 promoter activity in primary
cortical cell cultures and had no effect in neurons of the
Neuro-2A cell line. Given that at 3DIV, cortical primary
cultures consist of approximately 45 % progenitors and
55% differentiated neurons [10,22], these findings sug-
gest that activation of Er81 depends primarily on Pax6
transcriptional control in cortical progenitors, but activa-
tion/maintenance of Er81  expression in differentiated
neurons possibly involves other regulatory factors. To
identify such potential factors, we performed an in silico
search for potential upstream binding sites and identified
multiple binding sites for the transcription factors, REST/
NRSF and Brn2, both of which are important in cortical
neurogenesis [46,47]. These transcription factors could be
important for activation and/or maintenance of Er81
expression in cortical progenitors and subsets of differen-
tiated neurons.
It is interesting to note that both Pax6- and Ngn2-depend-
ent expression of Er81 in RG progenitors in vivo is con-
fined to progenitors of the rostrolateral cortex. To confirm
the functional significance of the Pax6-dependent control
sequence identified in the Er81 promoter, we developed a
transgenic mouse line in which the 2 kb Er81 promoter
region was placed upstream of a Cre recombinase
sequence. A detailed analysis of the resulting Er81Cre line
is a subject of a separate study. Results obtained thus far
indicate, however, that the expression of the LacZ reporter
in  Er81Cre:Gtrosa26tm1Sho  double-transgenic mice faith-
fully reproduces the known expression pattern of Er81 in
the developing telencephalon, including VZ progenitors
and subpopulations of L5 neurons, striatum, piriform cor-
tex and olfactory bulb (Fig. 2C,D; also [18,28]. Further-
more, the reporter LacZ staining was much fainter in the
medial than in the dorsal or lateral pallium. During the
process of submitting this paper, Langevin et al [18]
reported that a 2-kb region upstream of the zebrafish Er81
is active in the lateral, but not in the medial cortex of the
mouse, and identified Pax6-binding sites in a 1.3-kb
upstream region [18]. Thus, it is possible that Er81 pro-
moter activity in progenitors of the dorsal and lateral pal-
lium (rostrally) as well as in the whole caudal pallium
depends on combinatorial control by Pax6 and other
transcription factors. Such simultaneous binding of Pax6
and the transcription factors, Sox2 and Maf, in the δ-crys-
tallin and glucagon promoters, respectively, significantly
increases Pax6 transactivation ability [48,49]. Together,
these findings strongly suggest that an evolutionarily con-
served genetic interplay between Pax6 and Er81 is
involved in the regional specification of progenitor iden-
tity in the developing cortex.
Conclusion
In this paper we have shown that a direct genetic interac-
tion between the transcription factors, Pax6 and Er81, in
cortical VZ may be involved in the regional specification
of neuronal subtype identity of a set of layer 5 projection
neurons. The low-affinity binding of Pax6 to the 2-kb Er81
promoter suggests that only the high endogenous levels of
Pax6 in progenitors of the rostrolateral cortex are capable
of regulating Er81  promoter activity, an interpretation
that is consistent with the reported regional inhibition of
Er81 expression in Pax6-defficient mutants. The expres-
sion of Er81 in cortical germinative neuroepithelium in
other regions and in mature neurons may involve regula-
tion by other molecular determinants acting independ-
ently of, or together with, Pax6.
Methods
Plasmids and antibodies
CMV-Pax6 [46] was used for Pax6 expression in mamma-
lian cells. pGL3 basic served as the backbone for luciferase
reporter constructs. Er81(mut)-Luc was generated by site-
direct mutagenesis (Quick Change, Stratagene) using
Er81(wt)-Luc as a template.
The anti-Pax6 monoclonal (1:500, DSHB), anti-Pax6 pol-
yclonal (1:500, BABCO), anti-GFP (1:500, Chemicon),
anti-firefly Luciferase (1:100, Abcam), Alexa 488 goat
anti-mouse, and Alexa 594 goat anti-rabbit (1:400, Invit-
rogen) antibodies were used.
Identification of transcription factor binding sites in the 
Er81 promoter
To identify potential Pax6 binding sites within a 2-kb
region of the mouse Er81  promoter, we utilized the
sequence analysis package, GCG [17], and the previously
reported Pax6 consensus-binding site [16]. MatInspector
software was used to search for additional transcription
factor binding sites in Er81 promoter [50].
Determination of Pax6 DNA binding (EMSA)
EMSA was performed as described by Bäumer et al [51]
with some modifications. Briefly, Pax6 proteins were
expressed using the TNT in vitro transcription and transla-
tion system (Promega), according to the manufacturer'sBMC Developmental Biology 2008, 8:23 http://www.biomedcentral.com/1471-213X/8/23
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instructions. Double-stranded oligonucleotides (Fig. 1A)
were end-labeled using polynucleotide kinase and
gramma-P32ATP. The binding reaction was performed for
1 hr on ice in binding buffer (25 mM HEPES pH7.4, 10%
glycerol, 75 mM NaCl, 0.25 mM EDTA, 1 mM DTT, 0.1%
Nonidet P-40, 1 mM MgCl2, protease inhibitor cocktail)
containing 0.5 μg poly-dI-dC, double-stranded oligonu-
cleotides (with radial activity at 35000 cpm) and 10 μl of
in vitro-translated Pax6 protein. For antibody supershift
analyses, 0.5 μl of Pax6 polyclonal rabbit antibody
(Babco) was added and samples were incubated for an
additional 15 min. Samples were load onto 4% TAE poly-
acrylamide gels and electrophoresed at 10 V/cm to resolve
complexes. Gels were dried and processed for autoradiog-
raphy.
Chromatin immunoprecipitation (ChIP) assay
Chromatin was extracted from E15.5 mouse cortices.
ChIP assays were performed according to the kit manufac-
ture's instructions (Upstate Biotechnology) using polyclo-
nal Pax6 antibodies (BABCO) to immunoprecipitate
Pax6-binding chromatin fragments, with pre-immune
serum and polyclonal GFP antibodies (Abcam) as immu-
noprecipitation controls (10 μg antibody per immuno-
precipitation).
Generation of an Er81Cre transgenic mouse line
A 2-kb region upstream from the starting codon of the
mouse Er81 gene was amplified as an NheI/Not fragment
using the Expand Long Template PCR kit (Roche) and
cloned into a Cre-IRES-GFP-Intron-pA plasmid [52,53] in
pSL1180 (Pharmacia). Er81Cre mice were generated by
pronuclear microinjection. Transgenic mice were identi-
fied by PCR analysis or GFP-fluorescence and maintained
in a C57BL6/J background. Animals have been handled
with permission of the Bezirksregierung Braunschweig in
accordance with the German Animal Protection Law.
Cell culture and cell transfection
HeLa cells were maintained and cultured in DMEM
medium containing 10% fetal calf serum (FCS). Cells
were transfected using Lipofectamine 2000 (Invitrogen),
according to the supplier's instructions.
Primary cortical cell culture and electroporation
The two telencephalic hemispheres were isolated under
sterile conditions in Ca2+/Mg2+-free Hanks Balanced Salt
Solution containing 10 mM HEPES (HBSS/HEPES). After
washing twice with fresh HBSS/HEPES solution, cells were
incubated for 18 min at 37°C in 0.25% Trypsin/EDTA
(Sigma). The tissue was then dissociated mechanically by
triturating with a fire-polished, serum-coated Pasteur
pipette, then centrifuged for 5 min at 1000 rpm, washed
and resuspended in DMEM medium plus 10% FCS. Pri-
mary cortical cells were electroporated using a nucle-
otransfection device (Amaxa) and then cultured for 3 days
on coverslips coated with poly-D-lysine and Sato medium
(DMEM, 100 μg/ml albumin, 100 μg/ml apo-transferrin,
16 μg/ml putrescine, 0.06 ng/ml progesterone, 40 ng/ml
selenium, 5 μg/ml insulin, 1 mM sodium pyruvate and 2
mM L-glutamine) [23].
Luciferase assay
HeLa cells or primary cortical cells were lysed and assayed
for Luciferase activity according to the assay manufac-
turer's instructions (Promega).
In ovo chick electroporation
Chick embryos at stage 11–12 (36–48 hr old) were elec-
troporated as described in Marquardt et al [54]. Briefly,
2.5  μg/μl of Er81-Luc  and 2.5 μg/μl of CMV-Pax6  (or
CMV-Gfp) were co-electroporated into the hindbrain or
midbrain of chick embryos. After 1–2 days, embryos were
collected and analyzed using immunohistochemistry. At
least 10 electroporated embryos were analyzed in each
experiment.
X-Gal staining
Embryos from timed mating were fixed and stained over-
night with X-Gal at 37°C as described previously [27,53].
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